{"url_path":"/sec/alzn/10-k/2026/item-3","section_key":"item-3","section_title":"Item 3 ****LEGAL PROCEEDINGS**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","accession_number":"0001214659-26-008832","cik":"0001677077","ticker":"ALZN","issuer_name":"Alzamend Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008832-index.html","primary_entity_key":"0001677077","primary_entity_name":"Alzamend Neuro, Inc."},"word_count":93,"has_tables":true,"body_markdown":"**ITEM 3.****LEGAL PROCEEDINGS**\n\n** **\n\nWe are subject to various\nclaims and legal actions arising in the ordinary course of our business. Any such litigation could be very costly and could distract our\nmanagement from focusing on operating our business. The existence of any such litigation could harm our business, results of operations\nand financial condition. Results of actual and potential litigation are inherently uncertain. An unfavorable result in a legal proceeding\ncould adversely affect our reputation, financial condition and operating results. There are no legal proceedings or arbitration proceedings\ncurrently pending against our company."}